AI in ophthalmology: Top items of 2024 so far
Click Here to Manage Email Alerts
In 2024, the discussion around AI’s role in medicine continues to grow, including in eye care.
Check out Healio’s recent coverage exploring the developing relationship between AI and ophthalmology.
Image: Adobe Stock
Shift to VR, AR, AI, robotics inevitable for ophthalmologists
For many senior ophthalmologists, the entry of virtual reality, augmented reality, AI and robotics into our lives and practices is intimidating. Read more.
BLOG: AI and ophthalmology marketing: Pandora’s box or Cassandra’s prophecy?
Ophthalmology practices increasingly face a choice in how their marketing operations are run: Embrace AI-enabled systems and stay competitive, or maintain traditional but proven promotional strategies and possibly be left behind. Read more.
AI in retina moving toward real-world practice
Retinal diseases are a major cause of severe vision loss, with numbers constantly increasing due to the aging of the population, the diabetes epidemic and the growing prevalence of high myopia. Read more.
VIDEO: AI model helps predict anti-VEGF response in diabetic macular edema
In this Healio Video Perspective from Kiawah Eye, Joe Luvisi, MD, discusses the use of AI to predict response to anti-VEGF therapy in diabetic macular edema. Watch here.
FDA grants de novo authorization to AI-powered Scanly Home OCT device
The FDA granted de novo marketing authorization to Notal Vision for the patient self-operated AI-powered Scanly Home OCT device. Read more.
Collapse
Healio Coverage
Read more about
Click Here to Manage Email Alerts